4
Changes in Ownership
Aurinia Pharmaceuticals Inc. Filed Acc 0001628280-21-009847
Ex Vice President of Research acquired 40,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Huizinga Robert Bindert Ex Vice President of Research | 2021-05-11 | Option exercise | +40,000 | $3.02 | $120,800 | 143,592 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Huizinga Robert Bindert Ex Vice President of Research | 2021-05-11 | Option exercise · Stock Option (right to buy) | −40,000 | 0 | D: show line 2 in the form |
Loading xslF345X03/wf-form4_162076816300353.xml…